Galderma Labs Expands Collaborations Roster

Galderma Laboratories LP announces an expansion to its roster of collaborations in the US with professional-grade skincare brands, REVISION SKINCARE, ALASTIN Skincare, and SENTÉ, to bring additional value to aesthetic providers and their patients.

The expansion is a strategic move due largely to the proven success of Galderma’s long-standing, ongoing collaborations with Colorescience and Mentor Breast Implants, the company notes in a news release.

“Galderma strives to build new relationships within the aesthetic market and develop innovative marketing promotions to benefit our customers and their patients,” says Alisa Lask, vice president and general manager of Galderma’s US Aesthetic Business.

“Through these unique collaborations, aesthetic providers can now offer their patients a variety of premium skincare products along with their facial injectable treatments.”

The collaborations include certain Galderma aesthetic dermal fillers and physician-dispensed skincare products. With a qualifying purchase of Galderma dermal fillers, aesthetic injectors will receive the skincare products to offer to their patients to use as part of their ongoing beauty routine.

“The popularity of non-surgical treatments is rising and providing distinct offers to my patients is important because it allows me to deliver customized and memorable patient experiences,” states Dr Robyn Siperstein, MD, a board-certified dermatologist at Siperstein Dermatology Group, the release continues.

“With Galderma’s new professional skincare brand collaborations, it allows me to focus on obtaining patient long-term loyalty and trust, as well as incentivizing my patients to come back for additional treatments and services.”

Consumers can learn about these offerings from participating aesthetic providers. In the future, Galderma is planning to leverage the one million members of the ASPIRE Galderma Rewards program to reach patients directly with unique benefits they can redeem from participating aesthetic providers.

[Source(s): Galderma, PR Newswire]